Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ONESOURCE SPECIALTY PHARMA LTD.

NSE : ONESOURCEBSE : 544292ISIN CODE : INE013P01021Industry : Pharmaceuticals & DrugsHouse : Private

BSE1452.1594.9 (+6.99 %)

PREV CLOSE ( ) 1357.25

OPEN PRICE ( ) 1343.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 61553

TODAY'S LOW / HIGH ( )1343.25 1489.00

52 WK LOW / HIGH ( )1075 2249.65

NSE1447.10113 (+8.47 %)

PREV CLOSE( ) 1334.10

OPEN PRICE ( ) 1352.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1447.10 (985)

VOLUME 840018

TODAY'S LOW / HIGH( ) 1344.50 1467.50

52 WK LOW / HIGH ( )1057 2248

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-06 2007

Management Info

Arun Kumar - Chairman Neeraj Sharma - Managing Director

Registered Office

Address Unit No. 902, Cyber One,Plot No - 4 & 6,Sector 30 A, Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022 2789 2924

Email cs@stelis.com

Website www.stelis.com

Registrars Details

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai

Listing : BSE, NSE

NEWS

12Feb OneSource Specialty Pharma informs abo
Pursuant to Regulation 30 read with read with Para A of Part A of Schedu..

11Feb OneSource Specialty Pharma informs ab
OneSource Specialty Pharma has informed that it enclosed Press Release i..

11Feb OneSource Specialty Pharma secures SFD
OneSource Specialty Pharma has received Saudi Food and Drug Authority (S..

11Feb OneSource Specialty Pharma moves up on
Onesource Specialty Pharma is currently trading at Rs. 1196.75, up by 3...

03Feb Onesource Specialty Pharma informs abo
Onesource Specialty Pharma has informed that it enclosed disclosure unde..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	-621.85	193.1
Gross Profit	-621.85	-214.55
Operating Profit	174.56	3869.57
Net Sales	2902.2	12995.89

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Emcure Pharma (BSE) 1653.60 (3.75%)	M.Cap ( in Cr)31350.53
Anthem Biosciences (BSE) 681.20 (5.44%)	M.Cap ( in Cr)38263.95
Mankind Pharma (BSE) 2040.25 (0.99%)	M.Cap ( in Cr)84227.30
Gland Pharma (BSE) 1728.75 (1.16%)	M.Cap ( in Cr)28482.27
Acutaas Chemicals (BSE) 2544.35 (0.75%)	M.Cap ( in Cr)20830.88

Shareholding Pattern

	NON-INSTITUTION	32.15%
	PROMOTERS	29.93%
	MUTUAL FUNDS/UTI	9.02%
	FI/BANKS/INSURANCE	2.53%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Motilal Oswal Manuf...	4.75
Motilal Oswal Focus...	4.48
Motilal Oswal Activ...	3.63
Motilal Oswal ELSS ...	3.27
Motilal Oswal Large...	3.22
JM Focused Fund-Reg(G)	3.11
JM ELSS Tax Saver Fund(G)	2.97

Risk Disclosures on Derivatives

Smart Quotes

ONESOURCE SPECIALTY PHARMA LTD.